HOWL(Werewolf Therapeutics, Inc.) · 财务报表

HOWL(Werewolf Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入—————
毛利润—————
营业利润−$50.09M−$56.06M−$40.50M−$73.59M−$60.68M
净利润−$49.98M−$53.81M−$37.37M−$70.52M−$60.82M
经营现金流−$42.88M−$40.60M−$32.61M−$56.19M−$60.29M
自由现金流−$43.37M−$44.21M−$33.38M−$56.44M−$60.29M
摊薄每股收益$-10.94$-1.86$-1.05$-1.63$-1.33

Werewolf Therapeutics, Inc. HOWL